Medicare Enrolled

Dr. Irving Ingraham, MD

Gastroenterology · Peabody, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2 ESSEX CENTER DRIVE, Peabody, MA 01960
9785326111
In practice since 2006 (20 years)
NPI: 1073569760 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ingraham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ingraham? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ingraham

Dr. Irving Ingraham is a gastroenterology specialist in Peabody, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ingraham performed 496 Medicare services across 372 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ingraham received a total of $3,744 from 19 pharmaceutical and/or device companies across 39 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ingraham is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 496 Medicare services $3,744 industry payments

Medicare Practice Summary

Medicare Utilization ↗
496
Medicare services
Bottom 44% in MA for gastroenterology
372
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~25 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 234 $94 $544
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
 143 $135 $763
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 31 $63 $386
Hydrogen breath test
A test that measures hydrogen levels in your breath to help evaluate stomach and bowel symptoms.
 30 $68 $1,033
New patient office visit, complex (60-74 min) 30 $166 $991
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
 16 $100 $544
Esophageal motility study
A test that evaluates the movement and function of the esophagus.
 12 $47 $270
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,744
Total received (2018-2024)
Avg $624/year across 6 years
Top 30% in MA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
19
Companies
39
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,675 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$69 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$558
2023
$1,015
2022
$639
2020
$66
2019
$694
2018
$771

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$129
Intercept Pharmaceuticals, Inc.
$125
GENZYME CORPORATION
$111
ABBVIE INC.
$98
Gilead Sciences, Inc.
$95
Top 3 companies account for 65.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$834
Intercept Pharmaceuticals, Inc.
$486
E.R. Squibb & Sons, L.L.C.
$270
AbbVie, Inc.
$225
Ethicon Inc.
$217
INTERCEPT PHARMACEUTICALS, INC.
$193
Takeda Pharmaceuticals U.S.A., Inc.
$190
Covidien LP
$169
Janssen Scientific Affairs, LLC
$132
Janssen Biotech, Inc.
$129
PFIZER INC.
$127
UCB, Inc.
$125
Ardelyx, Inc.
$116
GENZYME CORPORATION
$111
Regeneron Healthcare Solutions, Inc.
$104
Merck Sharp & Dohme Corporation
$99
Gilead Sciences, Inc.
$95
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$88
Endogastric Solutions, Inc
$32
Top 3 companies account for 42.5% of all-time payments
Associated products mentioned in payments ›
Barrx · Cimzia · DUPIXENT · ENTYVIO · ESOPHYX · Epclusa · IBSRELA · INFLECTRA · LINX Reflux Management System · Mavyret · OCALIVA · RENFLEXIS · RINVOQ · SKYRIZI · STELARA · TREMFYA · XELJANZ · XIFAXAN · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in Peabody?
Compare gastroenterologists in the Peabody area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
316
Per 100K population
39.1
County median income
$99,431
Nearest hospital
NORTH SHORE MEDICAL CENTER -
5.2 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ingraham is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ingraham experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ingraham performed 234 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ingraham receive payments from pharmaceutical companies?
Yes. Dr. Ingraham received a total of $3,744 from 19 companies across 39 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ingraham's costs compare to other gastroenterologists in Peabody?
Dr. Ingraham's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ingraham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Peabody
Browse gastroenterologists in Peabody ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in MA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in MA
Which MA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Intercept Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Intercept Pharmaceuticals, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →